{"id":"https://openalex.org/W2492725150","doi":"https://doi.org/10.1007/978-1-349-07431-0_73","title":"Role of Hydroxylase Cofactor in Regulating Dopamine Synthesis: Relevance to Neurological Disorders","display_name":"Role of Hydroxylase Cofactor in Regulating Dopamine Synthesis: Relevance to Neurological Disorders","publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W2492725150","doi":"https://doi.org/10.1007/978-1-349-07431-0_73","mag":"2492725150"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-349-07431-0_73","doi":"https://doi.org/10.1007/978-1-349-07431-0_73","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-349-07431-0_73","pdf_url":null,"source":{"id":"https://openalex.org/S4306463716","display_name":"Palgrave Macmillan UK eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319703","host_organization_name":"Palgrave Macmillan","host_organization_lineage":["https://openalex.org/P4310319703","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Palgrave Macmillan","Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dopaminergic Systems and their Regulation","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W627164170","display_name":"Dopaminergic Systems and their Regulation"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047169279","display_name":"Leonard P. Miller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Miller","raw_affiliation_strings":["Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017122855","display_name":"Peter A. LeWitt","orcid":"https://orcid.org/0000-0002-4976-4445","observed_orcids":["https://orcid.org/0000-0002-4976-4445"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Lewitt","raw_affiliation_strings":["Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106182451","display_name":"Thomas R. Insel","orcid":"https://orcid.org/0000-0001-5031-0160","observed_orcids":["https://orcid.org/0000-0001-5031-0160"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Insel","raw_affiliation_strings":["Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110018061","display_name":"R. Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Levine","raw_affiliation_strings":["Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078460231","display_name":"Mika Scheinin","orcid":"https://orcid.org/0000-0001-7579-9126","observed_orcids":["https://orcid.org/0000-0001-7579-9126"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Sheinin","raw_affiliation_strings":["Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061188066","display_name":"Walter M. Lovenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Lovenberg","raw_affiliation_strings":["Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Neuropharmacology Branch, NIMH, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"Section on Biochemical Pharmacology, NHLBI, NIH, Bethesda, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210106489"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.43308081,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"471","last_page":"474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13481","display_name":"Neurological diseases and metabolism","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tetrahydrobiopterin","display_name":"tetrahydrobiopterin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/bh4","display_name":"BH4","score":0.7580000162124634},{"id":"https://openalex.org/keywords/dopamine-synthesis","display_name":"dopamine synthesis","score":0.7519999742507935},{"id":"https://openalex.org/keywords/tyrosine-hydroxylase","display_name":"tyrosine hydroxylase","score":0.9909999966621399},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9279999732971191},{"id":"https://openalex.org/keywords/dystonia","display_name":"dystonia","score":0.996999979019165},{"id":"https://openalex.org/keywords/monoamine-metabolites","display_name":"monoamine metabolites","score":0.7310000061988831},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.9810000061988831},{"id":"https://openalex.org/keywords/aminergic-neurons","display_name":"aminergic neurons","score":0.796999990940094},{"id":"https://openalex.org/keywords/neurotransmitter-synthesis","display_name":"neurotransmitter synthesis","score":0.5519999861717224},{"id":"https://openalex.org/keywords/neurological-disorders","display_name":"neurological disorders","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.794520914554596},{"id":"https://openalex.org/C2776145790","wikidata":"https://www.wikidata.org/wiki/Q419808","display_name":"Tetrahydrobiopterin","level":4,"score":0.7922859787940979},{"id":"https://openalex.org/C159167319","wikidata":"https://www.wikidata.org/wiki/Q420766","display_name":"Tyrosine hydroxylase","level":3,"score":0.7754464149475098},{"id":"https://openalex.org/C197957613","wikidata":"https://www.wikidata.org/wiki/Q407280","display_name":"Cofactor","level":3,"score":0.5636491179466248},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.5550169348716736},{"id":"https://openalex.org/C2778559928","wikidata":"https://www.wikidata.org/wiki/Q906492","display_name":"Dystonia","level":2,"score":0.5462250113487244},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.47216078639030457},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.4721370339393616},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.451360285282135},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.4175344705581665},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4040558934211731},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4006314277648926},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3732038736343384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3554396629333496},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.31947892904281616},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3176589906215668},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2323567271232605},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2308032512664795},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.1431940197944641},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.13061946630477905},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-349-07431-0_73","doi":"https://doi.org/10.1007/978-1-349-07431-0_73","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-349-07431-0_73","pdf_url":null,"source":{"id":"https://openalex.org/S4306463716","display_name":"Palgrave Macmillan UK eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319703","host_organization_name":"Palgrave Macmillan","host_organization_lineage":["https://openalex.org/P4310319703","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Palgrave Macmillan","Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dopaminergic Systems and their Regulation","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1965963335","https://openalex.org/W1966313692","https://openalex.org/W2024495771","https://openalex.org/W2086955825"],"related_works":["https://openalex.org/W2276074169","https://openalex.org/W2054984086","https://openalex.org/W2106964842","https://openalex.org/W2086955825","https://openalex.org/W2019954839","https://openalex.org/W2025540216","https://openalex.org/W2082667395","https://openalex.org/W1977453190","https://openalex.org/W1990356750","https://openalex.org/W2137298513"],"abstract_inverted_index":{"Over":[0],"the":[1,22,45,109,117,121],"past":[2],"several":[3],"years":[4],"there":[5],"has":[6],"been":[7],"an":[8],"emergence":[9],"of":[10,16,24,27,70,112,120],"interest":[11],"in":[12,21,57,62,137],"a":[13,25,67],"possible":[14],"role":[15],"hydroxylase":[17,114],"cofactor":[18,93,122,125,141],"(tetrahydrobiopterin,":[19],"BH4)":[20],"pathophysiology":[23],"number":[26],"neurological":[28],"disorders":[29],"such":[30],"as":[31],"Parkinson\u2019s":[32,145],"disease":[33,146],"and":[34,51,80,128],"dystonia":[35],"(Yamaguchi":[36],"et":[37,41,88],"al.,":[38,89],"1982;":[39],"Williams":[40],"al,":[42],"1980).":[43],"With":[44],"known":[46,75],"relationship":[47],"between":[48],"dopamine-mediated":[49],"neurotransmission":[50],"Parkinsonism":[52],"efforts":[53],"at":[54],"directly":[55],"increasing":[56,91],"vivo":[58],"dopamine":[59,78],"synthesis":[60,79],"rates":[61],"surviving":[63],"neurons":[64,86],"could":[65],"constitute":[66],"successful":[68],"mode":[69],"intervention.":[71],"Since":[72],"BH4":[73],"is":[74,81],"to":[76,98,126,142],"support":[77],"exclusively":[82],"localized":[83],"within":[84],"aminergic":[85],"(Levine":[87],"1981),":[90],"endogenous":[92],"levels":[94,136],"might":[95],"subsequently":[96],"lead":[97],"increased":[99],"neurotransmitter":[100],"synthesis.":[101],"We":[102],"investigated":[103],"this":[104],"approach":[105],"by":[106],"(1)":[107],"examining":[108],"kinetic":[110],"properties":[111],"tyrosine":[113],"(TH)":[115],"using":[116],"natural":[118],"isomer":[119],"(2)":[123],"administering":[124,140],"primates":[127],"monitoring":[129],"its":[130],"appearance":[131],"along":[132],"with":[133,144],"monoamine":[134],"metabolite":[135],"CSF":[138],"(3)":[139],"patients":[143],"or":[147],"dystonia.":[148]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-08-23T00:00:00"}